Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.000001
-0.011099 (-99.99%)
At close: Sep 18, 2026
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $1 as of September 25, 2026. Its market cap has decreased by -99.99% in one year.
Market Cap
1.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 1.00, a decrease of -100.00%. That is a compound annual growth rate of -95.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.00 | -99.99% |
| Dec 31, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthera Pharmaceuticals | 26.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| 9 Meters Biopharma | 14.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |
| Notable Labs | 10.00 |